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EDITORIAL COMMENT
Testing Coronary Flow Reserve
Without a Provocative Stress
A “BOLD” Approach*
Francis J. Klocke, MD, MACC,
Debiao Li, PHD
Chicago, Illinois
The importance of identifying clinically important coronary
stenoses noninvasively continues to stimulate interest in
improved and/or less complex techniques for evaluating
regional limitations in coronary flow reserve. The electro-
cardiographic, echocardiographic, and radionuclide ap-
proaches used in routine practice all employ exercise or
pharmacologic stress to “unmask” areas of myocardium
having normal resting perfusion but limited vasodilatory
reserve. The possibility of identifying clinically important
reductions in regional reserve without a provocative stress
has intrigued several investigators and is addressed in
coronary patients in this issue of the Journal in the study by
Wacker et al. (1) using blood oxygenation level-dependent
(BOLD) magnetic resonance imaging (MRI).
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The BOLD imaging capitalizes on the fact that deoxy-
genated hemoglobin in blood changes proton signals in a
fashion that can be imaged to reflect the level of blood
oxygenation (2). Increases in O2 saturation increase the
BOLD imaging signal (T2* in this study), whereas decreases
diminish it. Efforts to utilize BOLD imaging in the heart
have previously focused on responses to pharmacologically
induced coronary vasodilation (3–6). Because the increase
in coronary flow produced by adenosine and dipyridamole
usually occurs without a major increase in myocardial
oxygen demand, coronary venous oxygen saturation nor-
mally increases from its usual value of 20% to 30% to 70%
to 80%. When autoregulatory coronary vasodilation is
required to counteract the effect of a proximal stenosis under
resting conditions, regional coronary reserve is reduced and
the increment in venous oxygen saturation during pharma-
cologic vasodilation is less than in areas without stenosis.
The resultant regional differences in blood oxygen level (i.e.,
regional differences in deoxyhemoglobin concentration) are
detected as regional differences in T2*.
The BOLD imaging signal is also affected by the amount
of blood contained within the left ventricular vasculature,
which this discussion will refer to as coronary blood volume
(CBV). Coronary blood volume normally makes up 6% to
15% of left ventricular mass (7). As CBV increases, each
unit volume of ventricle, that is, each voxel in a myocardial
image, contains a slightly higher proportion of blood and a
correspondingly smaller proportion of heart tissue. Thus,
even at a stable level of oxygenation, the number of
deoxygenated hemoglobin molecules within a voxel in-
creases as CBV increases, causing a proportionate decrease
in T2*. When CBV increases during pharmacologic vaso-
dilation, the net effect on T2* reflects the increase caused by
the increased level of blood oxygenation counterbalanced by
any decrease resulting from the change in CBV. In the
current study, increases in T2* in response to dipyridamole
averaged 10 5(SD)% in apparently healthy volunteers (1).
Several groups have now reported that CBV is also
increased under resting conditions in areas supplied by
stenotic coronary arteries (8–11). Using high-speed com-
puted tomography in a canine model of epicardial coronary
stenosis, Ritman’s laboratory found that CBV increased by
25% in response to an epicardial stenosis producing a
40-mm trans-stenotic pressure gradient (but no change in
resting myocardial blood flow) (Fig. 5 in Wu et al. [9]).
Coronary blood volume decreased slightly, but remained
substantially elevated above its original value, as the trans-
stenotic pressure gradient was increased to 100 mm Hg
(and resting flow was impaired). Lindner et al. (10) and Wu
et al. (11) subsequently reported that autoregulatory-
induced increases in CBV could also be quantified using
myocardial contrast echocardiography. In addition, Lindner
et al. (10) confirmed that CBV increases progressively with
the degree of stenosis until autoregulatory vasodilator re-
serve is exhausted.
Bauer, Ertl, Wacker, and colleagues (1,5,12) in Wuer-
zburg have contributed significantly to the study of myo-
cardial applications of BOLD imaging. They have now
examined regional values of T2* under resting conditions as
well as during dipyridamole-induced vasodilation in 16
patients with clinically evident angina, single-vessel coro-
nary artery disease (70% stenosis), normal resting left
ventricular wall motion and positive stress echocardio-
graphic studies (1). Their data under resting conditions
(Fig. 3, left panel in Wacker et al. [1]) are noteworthy. A
regional reduction in T2*, corresponding to a relative in-
crease in deoxyhemoglobin, was apparent in the area per-
fused by the stenotic artery in every case illustrated. Values
of T2* in stenotic areas averaged 31  9% less than in
nonstenotic areas. Thus, clinically meaningful stenoses in
these patients were apparent without a provocative stress.
This finding presumably resulted from increases in CBV
associated with autoregulatory vasodilation required to
maintain normal blood flow under resting conditions. The
morphologic studies of Kassab et al. (13) indicate that 36%
of the total left ventricular CBV normally resides in vessels
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200 m in diameter. Because of their relative length,
capillaries appear to account for 90% of the blood con-
tained within these vessels (13). Because autoregulation
occurs primarily in arterioles 100 m (14), autoregulatory
increases in CBV involve capillaries and capillary recruit-
ment. Capillary recruitment may also involve changes in
microvessel hematocrit and flux of erythrocytes through
capillaries. By increasing the proportion of blood in each
voxel imaged, the autoregulatory increases in CBV appar-
ently increased the amount of deoxyhemoglobin contained
in capillaries and venules in voxels within the stenotic area.
Findings during dipyridamole-induced global coronary
vasodilation were compatible with the expending of normal
vasodilator reserve to maintain resting flow. Although
regional differences in T2* between normal and stenotic
areas increased on average to 43  21%, responses in
individual patients were quite variable (Fig. 3, right panel in
Wacker et al. [1]). The variability no doubt reflected
different degrees of residual flow reserve in individual
stenotic beds. The several patients who showed no clear
change presumably had lesions that required utilization of
nearly all vasodilator reserve under resting conditions. In-
deed, dipyridamole precipitated angina in five individuals.
As Wacker et al. (1) carefully point out, this investigation
is a pilot study demonstrating that a noncontrast MRI
technique can detect regional differences in BOLD signal in
patients with isolated coronary stenoses of sufficient severity
to produce clinical angina and abnormal responses to stress
echocardiography. Its applicability to the broad spectrum of
coronary disease merits further examination, particularly in
regard to findings under resting conditions. However, the
degree to which BOLD imaging technology can continue to
be improved may be a major consideration as studies
proceed. Several relevant issues, such as superimposed
susceptibility artifacts, are discussed by Wacker et al (1). In
addition, although a linear relationship between BOLD
signal and regional differences in flow has been demon-
strated over the full range of pharmacologic vasodilation in
a canine preparation, the degree of scatter in the relationship
remains problematic (6) (Fig. 6 in Wright et al. [6]). The
degree to which higher field strength magnets and other
potential improvements can improve the sensitivity and
specificity that can be achieved using clinical MRI systems
may determine the ultimate role of BOLD imaging in the
noninvasive evaluation of coronary artery disease.
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